These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25041401)

  • 1. Lupus anticoagulant testing and anticoagulation do not mix: quantitation of discrepant results and potential approaches to reduce false positives.
    Chandler JB; Torres R; Rinder HM; Tormey CA
    Br J Haematol; 2014 Dec; 167(5):704-7. PubMed ID: 25041401
    [No Abstract]   [Full Text] [Related]  

  • 2. Rebuttal to: strong lupus anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.
    Bailleul E; Van Vaerenbergh K; Lust A
    Thromb Haemost; 2005 Sep; 94(3):687; author reply 688. PubMed ID: 16268495
    [No Abstract]   [Full Text] [Related]  

  • 3. The Russell viper venom time (RVVT) test for investigation of lupus anticoagulant (LA).
    Favaloro EJ
    Am J Hematol; 2019 Nov; 94(11):1290-1296. PubMed ID: 31379004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivaroxaban and false positive lupus anticoagulant testing.
    Merriman E; Kaplan Z; Butler J; Malan E; Gan E; Tran H
    Thromb Haemost; 2011 Feb; 105(2):385-6. PubMed ID: 21103666
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant.
    Thom J; Ivey L; Gilmore G; Eikelboom JW
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):353-7. PubMed ID: 15166923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives.
    Favaloro EJ; Mohammed S; Curnow J; Pasalic L
    Pathology; 2019 Apr; 51(3):292-300. PubMed ID: 30665674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus-anticoagulant testing at NOAC trough levels.
    Ratzinger F; Lang M; Belik S; Jilma-Stohlawetz P; Schmetterer KG; Haslacher H; Perkmann T; Quehenberger P
    Thromb Haemost; 2016 Aug; 116(2):235-40. PubMed ID: 27075441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of the Taipan snake venom assay in assessing lupus anticoagulant status in individuals receiving or not receiving an oral vitamin K antagonist.
    Parmar K; Lefkou E; Doughty H; Connor P; Hunt BJ
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):271-5. PubMed ID: 19530340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH.
    Tripodi A; de Laat B; Wahl D; Ageno W; Cosmi B; Crowther M;
    J Thromb Haemost; 2016 Nov; 14(11):2304-2307. PubMed ID: 27860336
    [No Abstract]   [Full Text] [Related]  

  • 10. Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors.
    Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
    Int J Lab Hematol; 2021 Aug; 43(4):771-778. PubMed ID: 33974363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dilute Russell's viper venom time.
    Radhakrishnan K
    Methods Mol Biol; 2013; 992():341-8. PubMed ID: 23546726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixing studies for lupus anticoagulant: mostly yes, sometimes no.
    Favaloro E
    Clin Chem Lab Med; 2020 Mar; 58(4):487-491. PubMed ID: 31874094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct thrombin inhibitors and factor xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant.
    Olah Z; Szarvas M; Bereczky Z; Kerenyi A; Kappelmayer J; Boda Z
    Arch Pathol Lab Med; 2013 Jul; 137(7):967-73. PubMed ID: 23808469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.
    Ząbczyk M; Kopytek M; Natorska J; Undas A
    Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus Anticoagulant Testing: Diluted Russell Viper Venom Time (dRVVT).
    Pengo V; Bison E; Banzato A; Zoppellaro G; Jose SP; Denas G
    Methods Mol Biol; 2017; 1646():169-176. PubMed ID: 28804828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a new commercial dilute prothrombin time in the diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2008; 123(2):404-11. PubMed ID: 18495217
    [No Abstract]   [Full Text] [Related]  

  • 18. Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity.
    Moore GW; Peyrafitte M; Dunois C; Amiral J
    Lupus; 2018 Jan; 27(1):95-104. PubMed ID: 28549386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus anticoagulant testing using two parallel methods detects additional cases and predicts persistent positivity.
    Simmons DP; Herskovits AZ; Battinelli EM; Schur PH; Lemire SJ; Dorfman DM
    Clin Chem Lab Med; 2018 Jul; 56(8):1289-1296. PubMed ID: 27305702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients.
    Moore GW; Culhane AP; Maloney JC; Archer RA; Breen KA; Hunt BJ
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):477-80. PubMed ID: 26656903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.